Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
5,169,697
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
679,166
-
Shares change
-
+4,026
-
Total reported value, excl. options
-
$7,488,174
-
Value change
-
+$53,470
-
Number of buys
-
1
-
Number of sells
-
-2
-
Price
-
$11.00
Significant Holders of CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) as of Q4 2023
9 filings reported holding CERO - CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share as of Q4 2023.
CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 679,166 shares
of 5,169,697 outstanding shares and own 13% of the company stock.
Largest 10 shareholders include METEORA CAPITAL, LLC (242,687 shares), Mint Tower Capital Management B.V. (141,089 shares), Yakira Capital Management, Inc. (108,103 shares), CLEAR STREET LLC (54,600 shares), Walleye Capital LLC (47,936 shares), BERKLEY W R CORP (47,199 shares), Walleye Trading LLC (26,964 shares), GEODE CAPITAL MANAGEMENT, LLC (10,588 shares), Shaolin Capital Management LLC (0 shares), and CANTOR FITZGERALD, L. P. (155,000 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.